What Was Behind Ariad's 40% Drop?

This episode of The Motley Fool's Market Checkup dives into the hottest headlines, looks at the biggest market movers in the health-care sector, and discusses the implementation of the Affordable Care Act, also known as Obamacare.

In this segment, analysts David Williamson and Max Macaluso discuss the reasons behind today's 40% drop in shares of Ariad Pharmaceuticals (NASDAQ: ARIA  ) , an oncology-focused biotech company that is facing major headwinds regarding its chronic myeloid leukemia drug Iclusig.

Game-changing biotechs

The best way to play the biotech space is to find companies that shun the status quo and, instead, discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report, "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (2) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 19, 2013, at 8:33 AM, marp11 wrote:

    ZLCS with z160 phase 2 trials results imminent will be the winner in bio tech this year,

    re formulated: z160 the first ion -channel

    NON OPIOID PAIN KILLER

    in pill form,,,Prialt finished, Lyrica done too.

    DD will show this.

  • Report this Comment On October 21, 2013, at 7:17 PM, Mega wrote:

    Damn you Ariad. I lost 300 points on my red thumb and once I give up, you plummet.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2690305, ~/Articles/ArticleHandler.aspx, 12/22/2014 9:56:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement